Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Denfeld

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 4, 2012
["Dangerous" cutaneous polyp. Exophytic cutaneous myxofibrosarcoma]B E Paredes, T Mentzel, R Denfeld
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 13, 2021
[Potassium hydroxide 5 % solution in actinic keratosis : A novel therapeutic approach in the lesion-directed treatment]U Reinhold, J Bai-Habelski, D Abeck, et al.
Science (New York, N.Y.)|May 6, 1994
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cellsC Renner, W Jung, U Sahin, et al.
International Journal of Cancer|July 9, 1993
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphomaC Pohl, R Denfeld, C Renner, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 4, 2012
["Dangerous" cutaneous polyp. Exophytic cutaneous myxofibrosarcoma]B E Paredes, T Mentzel, R Denfeld
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 13, 2021
[Potassium hydroxide 5 % solution in actinic keratosis : A novel therapeutic approach in the lesion-directed treatment]U Reinhold, J Bai-Habelski, D Abeck, et al.
Science (New York, N.Y.)|May 6, 1994
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cellsC Renner, W Jung, U Sahin, et al.
International Journal of Cancer|July 9, 1993
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphomaC Pohl, R Denfeld, C Renner, et al.
Pageof 1